C
Carolina De La Guardia
Researcher at Acharya Nagarjuna University
Publications - 11
Citations - 182
Carolina De La Guardia is an academic researcher from Acharya Nagarjuna University. The author has contributed to research in topics: Virus & Serology. The author has an hindex of 5, co-authored 11 publications receiving 122 citations.
Papers
More filters
Journal ArticleDOI
Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2.
Carolina De La Guardia,David E. Stephens,Hang T. Dang,Mario Quijada,Oleg V. Larionov,Ricardo Lleonart +5 more
TL;DR: The synthesis and antiviral activity evaluation of two compounds based on the quinoline scaffold, which has shown potential for the development of molecules with various biological activities, showed dose-dependent inhibition of dengue virus serotype 2 in the low and sub micromolar range.
Journal ArticleDOI
Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
TL;DR: An overview of the targets and progress that has been made in the quest for dengue virus entry inhibitors is provided, with a focus on the initial step in the infection.
Journal ArticleDOI
AFLP Polymorphisms Allow High Resolution Genetic Analysis of American Tegumentary Leishmaniasis Agents Circulating in Panama and Other Members of the Leishmania Genus
Carlos M. Restrepo,Carolina De La Guardia,Octavio E. Sousa,José E. Calzada,Patricia L. Fernández,Ricardo Lleonart +5 more
TL;DR: Results of this study demonstrate that AFLP polymorphisms can be informative for genetic characterization in Leishmania parasites, at both intra and inter-specific levels.
Journal ArticleDOI
Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2
TL;DR: Blind docking simulations were done to investigate the possible mode of binding, showing that all peptides appear to bind domain III of the protein and may be mostly stabilized by hydrophobic interactions.
Journal ArticleDOI
Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama
Alcibiades E. Villarreal,Giselle Rangel,Xu Zhang,Digna Wong,Gabrielle B Britton,Patricia L. Fernández,Ambar Pérez,Diana C Oviedo,Carlos M. Restrepo,María B. Carreirra,Dilcia Sambrano,Gilberto A. Eskildsen,Carolina De La Guardia,Julio A Flores-Cuadra,Jean-Paul Carrera,Yamitzel Zaldivar,Danilo Franco,Sandra López-Vergès,Dexi Zhang,Fangjing Fan,Baojun Wang,Xavier Sáez-Llorens,Rodrigo DeAntonio,Ivonne Torres-Atencio,Isabel Blanco,Fernando Diaz Subía,Laiss Mudarra,Aron Benzadon,Walter Valverde,Lineth López,Nicolás Hurtado,Neyla Rivas,Julio Jurado,Aixa Carvallo,Juan M. Rodríguez,Yaseikiry Perez,Johanna Morris,Odemaris Luque,David Cortez,Eduardo Ortega-Barria,Rao Kosagisharaf,Ricardo Lleonart,Chong Li,Amador Goodridge +43 more
TL;DR: In this paper, a lateral flow assay was used to identify specific IgM and IgG antibodies against SARS-CoV-2 and reported the seroprevalence estimates of these antibodies among health care workers and healthy volunteer blood donors in Panama.